Trial intelligence / Profile preview

Silymarin in Diabetic Nephropathy

NCT01003236Phase 2Completed

Sponsor
Shiraz University of Medical Sciences
Start
Oct 2010
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of silymarin in diabetic nephropathy (DN), sponsored by Shiraz University of Medical Sciences. Started Oct 2010; status: completed.

02

Drugs

silymarin
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT01003236.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01003236.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call